Results 201 to 210 of about 4,236,805 (394)
Optimizing PSMA-617-based inhibitors through charged linker modifications: Insights into structure-activity relationships. [PDF]
Geis NM +4 more
europepmc +1 more source
Effect of crosslinker multiplicity on the gel point in ATRP [PDF]
Du Prez, Filip +3 more
core +1 more source
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto +13 more
wiley +1 more source
Liganded LolCDE structures reveal a common substrate-LolE interaction guiding bacterial lipoprotein transport. [PDF]
Szewczyk P +4 more
europepmc +1 more source
Generation of two normal and tumour (cancerous) paired human cell lines using an established tissue culture technique and their characterisation is described. Cell lines were characterised at cellular, protein, chromosome and gene expression levels and for HPV status.
Simon Broad +12 more
wiley +1 more source
Recent advances in bispecific antibody-drug conjugates for breast cancer therapy. [PDF]
Ji X +7 more
europepmc +1 more source
The noncoding region of the genome plays a key role in regulating gene expression, and mutations within these regions are capable of altering it. Researchers have identified multiple functional noncoding mutations associated with increased cancer risk in the genome of breast cancer patients.
Arnau Cuy Saqués +3 more
wiley +1 more source
Determining the Optimal Heparin Binding Domain Distance in VEGF<sub>165</sub> Using Umbrella Sampling Simulations for Optimal Dimeric Aptamer Design. [PDF]
Lee JS, Go YJ, Rhee YM.
europepmc +1 more source

